You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
天大藥業(00455.HK)與中基長壽科學訂立戰略合作框架協議

格隆匯11月10日丨天大藥業(00455.HK)發佈公吿,2021年11月9日,公司與中基長壽科學(00767.HK)訂立戰略合作框架協議,就以下領域開展為期三年的戰略合作:(1)雙方將共同評估和投資有潛力的醫療科技和醫療服務項目,包括對其他上市公司及非上市項目的股權投資;(2)公司經營新型中醫館連鎖“天大館”和健康管理中心,將向其會員推薦中基長壽科學的長壽醫療服務,以及為中基長壽科學會員提供優質的中醫藥健康服務;和(3)中基長壽科學經營長壽醫學檢測服務和提供人體健康長壽科學解決方案,將向其會員推薦公司的中醫藥健康服務,以及為公司會員提供優質的長壽醫療服務。

公吿表示,公司貫徹實施“以發展中醫藥產業為基礎,發展創新藥物和醫療科技,發展優質醫療和保健服務”的戰略,致力成為立足中國,輻射全球的領先醫藥企業。公司認為,訂立框架協議有利於加強公司與戰略伙伴在投資發展和業務發展上的深度合作和資源共享,有利於發掘和評估在醫療科技和服務領域的潛在投資機會,有利於融合中醫藥、現代醫學和其它創新技術,為公司客户提供優質的醫療和保健服務。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account